259 related articles for article (PubMed ID: 11397667)
1. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe LR; Subbaramaiah K; Brown AM; Dannenberg AJ
Endocr Relat Cancer; 2001 Jun; 8(2):97-114. PubMed ID: 11397667
[TBL] [Abstract][Full Text] [Related]
2. The role of COX-2 inhibition in breast cancer treatment and prevention.
Arun B; Goss P
Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
Grossman HB
Drugs Today (Barc); 2003 Mar; 39(3):203-12. PubMed ID: 12730704
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
5. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.
Howe LR; Dannenberg AJ
Semin Oncol; 2002 Jun; 29(3 Suppl 11):111-9. PubMed ID: 12138405
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
Subbaramaiah K; Dannenberg AJ
Trends Pharmacol Sci; 2003 Feb; 24(2):96-102. PubMed ID: 12559775
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibitors in colorectal cancer.
Stoehlmacher J; Lenz HJ
Semin Oncol; 2003 Jun; 30(3 Suppl 6):10-6. PubMed ID: 12802790
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib with chemotherapy in colorectal cancer.
Blanke CD
Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
10. The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.
Singh-Ranger G; Mokbel K
Eur J Surg Oncol; 2002 Nov; 28(7):729-37. PubMed ID: 12431470
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitors in glioma therapy.
Giglio P; Levin V
Am J Ther; 2004; 11(2):141-3. PubMed ID: 14999366
[TBL] [Abstract][Full Text] [Related]
12. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
Bresalier RS
Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
[No Abstract] [Full Text] [Related]
13. COX-2 inhibitors: cancer trials test new uses for pain drug.
Michalowski J
J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
[No Abstract] [Full Text] [Related]
14. The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.
Rahme E; Barkun AN; Toubouti Y; Bardou M
Gastroenterology; 2003 Aug; 125(2):404-12. PubMed ID: 12891542
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
[TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors in oncology.
Haller DG
Semin Oncol; 2003 Aug; 30(4 Suppl 12):2-8. PubMed ID: 14508721
[No Abstract] [Full Text] [Related]
17. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
18. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma.
Wun T; McKnight H; Tuscano JM
Leuk Res; 2004 Feb; 28(2):179-90. PubMed ID: 14654083
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitors for the prevention of breast cancer.
Howe LR; Dannenberg AJ
J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):31-43. PubMed ID: 14587862
[TBL] [Abstract][Full Text] [Related]
20. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
